Sprint Bioscience AB (publ) (STO:SPRINT)

Sprint Bioscience AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	46	110	121	22	191	163
Market Cap Growth	-8.82%	-8.82%	449.78%	-88.47%	17.26%	14.86%
Enterprise Value	21	79	66	-5	105	128
Last Close Price	0.66	1.56	1.71	0.54	4.72	7.19
Forward PE	1.32	2.01	2.01	2.01	2.01	2.01
PS Ratio	0.70	1.67	2.34	265.47	5.45	8.49
PB Ratio	4.97	11.91	4.36	0.78	2.71	17.82
P/TBV Ratio	4.97	11.91	4.36	0.78	2.71	17.82
P/FCF Ratio	-	-	5.93	-	-	-
P/OCF Ratio	-	-	5.30	-	-	-
EV/Sales Ratio	0.32	1.19	1.28	-	3.01	6.64
EV/FCF Ratio	-0.85	-	3.24	-	-	-
Debt / Equity Ratio	-	-	-	-	-	1.09
Asset Turnover	1.27	1.27	1.04	0.00	0.62	0.73
Quick Ratio	1.14	1.14	1.67	3.78	8.74	1.30
Current Ratio	1.14	1.14	1.67	3.78	8.74	1.33
Return on Equity (ROE)	-98.67%	-98.67%	-1.57%	-122.00%	-63.02%	-424.50%
Return on Assets (ROA)	-22.46%	-22.46%	-1.66%	-65.01%	-28.29%	-89.46%
Return on Capital (ROIC)	-63.32%	-63.32%	-2.96%	-76.81%	-35.53%	-156.14%
Earnings Yield	-39.66%	-16.55%	-0.36%	-273.08%	-13.13%	-26.26%
FCF Yield	-53.50%	-22.32%	16.85%	-268.02%	-22.41%	-19.78%
Buyback Yield / Dilution	-0.01%	-0.01%	-65.98%	-45.85%	-71.85%	-49.55%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.